๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Repaglinide - Medicines in Ireland

42 authorised products containing Repaglinide, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 42 authorised medicines
MedicineActive substanceLicence holderStatus
Enyglid 0.5 mg tablets
EU/1/09/580/1-6
Repaglinide KRKA, d.d., Novo mesto โ€”
Enyglid 1 mg tablets
EU/1/09/580/7-12
Repaglinide KRKA, d.d., Novo mesto โ€”
Enyglid 2 mg tablets
EU/1/09/580/13-18
Repaglinide KRKA, d.d., Novo mesto โ€”
NovoNorm 0.5 mg tablets
EU/1/98/076/004
Repaglinide Novo Nordisk A/S โ€”
NovoNorm 0.5 mg tablets
EU/1/98/076/005
Repaglinide Novo Nordisk A/S โ€”
NovoNorm 0.5 mg tablets
EU/1/98/076/006
Repaglinide Novo Nordisk A/S โ€”
NovoNorm 0.5 mg tablets
EU/1/98/076/007
Repaglinide Novo Nordisk A/S โ€”
NovoNorm 1 mg tablets
EU/1/98/076/011
Repaglinide Novo Nordisk A/S โ€”
NovoNorm 1 mg tablets
EU/1/98/076/012
Repaglinide Novo Nordisk A/S โ€”
NovoNorm 1 mg tablets
EU/1/98/076/013
Repaglinide Novo Nordisk A/S โ€”
NovoNorm 1 mg tablets
EU/1/98/076/014
Repaglinide Novo Nordisk A/S โ€”
NovoNorm 2 mg tablets
EU/1/98/076/018
Repaglinide Novo Nordisk A/S โ€”
NovoNorm 2 mg tablets
EU/1/98/076/019
Repaglinide Novo Nordisk A/S โ€”
NovoNorm 2 mg tablets
EU/1/98/076/020
Repaglinide Novo Nordisk A/S โ€”
NovoNorm 2 mg tablets
EU/1/98/076/021
Repaglinide Novo Nordisk A/S โ€”
Prandin
EU/1/00/162/002
Repaglinide Novo Nordisk A/S โ€”
Prandin
EU/1/00/162/003
Repaglinide Novo Nordisk A/S โ€”
Prandin
EU/1/00/162/004
Repaglinide Novo Nordisk A/S โ€”
Prandin
EU/1/00/162/005
Repaglinide Novo Nordisk A/S โ€”
Prandin
EU/1/00/162/006
Repaglinide Novo Nordisk A/S โ€”
Prandin
EU/1/00/162/007
Repaglinide Novo Nordisk A/S โ€”
Prandin
EU/1/00/162/008
Repaglinide Novo Nordisk A/S โ€”
Prandin
EU/1/00/162/009
Repaglinide Novo Nordisk A/S โ€”
Prandin
EU/1/00/162/010
Repaglinide Novo Nordisk A/S โ€”
Prandin
EU/1/00/162/011
Repaglinide Novo Nordisk A/S โ€”
Prandin
EU/1/00/162/012
Repaglinide Novo Nordisk A/S โ€”
Prandin
EU/1/00/162/013
Repaglinide Novo Nordisk A/S โ€”
Prandin
EU/1/00/162/014
Repaglinide Novo Nordisk A/S โ€”
Prandin
EU/1/00/162/015
Repaglinide Novo Nordisk A/S โ€”
Prandin
EU/1/00/162/016
Repaglinide Novo Nordisk A/S โ€”
Prandin
EU/1/00/162/017
Repaglinide Novo Nordisk A/S โ€”
Prandin
EU/1/00/162/018
Repaglinide Novo Nordisk A/S โ€”
PRANDIN
EU/1/00/162/001
Repaglinide Novo Nordisk A/S โ€”
Repaglinide Accord 0.5 mg tablets
EU/1/11/743/001-005
Repaglinide Accord Healthcare S.L.U. โ€”
Repaglinide Accord 1 mg tablets
EU/1/11/743/006-010
Repaglinide Accord Healthcare S.L.U. โ€”
Repaglinide Accord 2 mg tablets
EU/1/11/743/011-015
Repaglinide Accord Healthcare S.L.U. โ€”
Repaglinide Krka 0.5 mg tablets
EU/1/09/579/1-6
Repaglinide KRKA, d.d., Novo mesto โ€”
Repaglinide Krka 1 mg tablets
EU/1/09/579/7-12
Repaglinide KRKA, d.d., Novo mesto โ€”
Repaglinide Krka 2 mg tablets
EU/1/09/579/13-18
Repaglinide KRKA, d.d., Novo mesto โ€”
Repaglinide Teva 0.5 mg Tablet
EU/1/09/530/1-5
Repaglinide Teva Pharma B.V. โ€”
Repaglinide Teva 1 mg Tablet
EU/1/09/530/6-10
Repaglinide Teva Pharma B.V. โ€”
Repaglinide Teva 2 mg Tablet
EU/1/09/530/11-15
Repaglinide Teva Pharma B.V. โ€”
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 14 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.